Drugs Online

Drugs Online
HomeAlpha IndexCategories

Allergy

Anti Bacterial

Anti Convulsants

Anti Depressants

Anti Fungal

Anti Narcoleptic

Anti Viral

Antibiotics

Arthritis

Asthma

Birth Control

Blood Pressure

Cancer

Cardiovascular

Cholesterol

Diabetes

Diuretics

Eye Drops

Gastrointestinal

Hair Care

Herbal & Diet Supplements

Men's Health

Migraines

Muscle Relaxers

Nausea & Vomiting

Other

Pain Medicine

Pet Herbal Remedies

Prescription Drugs 1

Prescription Drugs 2

Prescription Drugs 3

Prescription Drugs 4

Prescription Drugs 5

Prescription Drugs 6

Prescription Drugs 7

Prescription Drugs 8

Prescription Drugs 9

Prescription Drugs 10

Prescription Drugs 11

Prescription Drugs 12

Prescription Drugs 13

Prescription Drugs 14

Prescription Drugs 15

Prescription Drugs 16

Prescription Drugs 17

Respiratory

Skin Care

Stop Smoking

Thyroid

Weight Loss

Women's Health

Drugs Online

Alphabetical Index

Categories

RECLIDE Vivazide

Drugs Online » Prescription Drugs 14 » RECLIDE Vivazide

Insulin is produced by the pancreas and is the main hormone responsible for controlling sugar levels in the blood. It normally makes the cells of the body remove excess sugar from the blood. People with type 2 diabetes (non-insulin dependent diabetes) have a deficiency of insulin and the cells of their bodies are also resistant to the action of insulin. This means that blood sugar levels can become too high. Gliclazide is a type of antidiabetic medicine known as a sulphonylurea. It is used to help lower blood sugar in people with type 2 diabetes. It works by acting on the cells in the pancreas that produce insulin. These cells are called beta cells and gliclazide causes them to produce more insulin. Gliclazide improves insulin production immediately after eating. This is called early or first phase insulin secretion and does not normally happen in people with type 2 diabetes. The enhanced insulin production results in a blood sugar lowering effect in response to meals or glucose as occurs naturally in non-diabetic people. Gliclazide is used when dietary measures weight loss and physical exercise are not enough to lower blood sugar levels in type 2 diabetes. Gliclazide has been shown to prevent blood cells called platelets from clumping together in the blood. It also increases the breakdown of blood clots that form within the blood vessels. This may help prevent the long-term complications of diabetes which may be partly due to changes in the blood vessels caused by these mechanisms.

Buy RECLIDE Vivazide and other Prescription Drugs 14 products online at Medstore.

743
Buy Online at Medstore - Click Here!

About RECLIDE Vivazide:

Product Type: Prescription Drugs 14

RECLIDE ( Vivazide Starlix Diaglyk Diamicron Generic Gliclazide )

RECLIDE (Vivazide Starlix Diaglyk Diamicron Generic Gliclazide)

Vivazide Starlix Diaglyk Diamicron Generic Gliclazide

40mg Tabs 100 (10 x 10) Vivazide Starlix Diaglyk Diamicron Generic Gliclazide RECLIDE

View more Prescription Drugs 14

Previous Product  Next Product

Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.